Quick Heal Technologies Employee Stock Options
Quick Heal Technologies Limited has allotted 1,210 equity shares following the exercise of options under its ESOP Scheme 2021. This increases the company's total issued share capital to Rs. 54.28 Crore.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
18 announcements with these filters
Quick Heal Technologies Limited has allotted 1,210 equity shares following the exercise of options under its ESOP Scheme 2021. This increases the company's total issued share capital to Rs. 54.28 Crore.
Quick Heal is pivoting from a declining B2C antivirus market to Enterprise cybersecurity (Seqrite), showing early signs of recovery.
Quick Heal appointed Shailesh Shinde as Company Secretary and KMP effective October 27, 2026. The board also approved an internal auditor and nodal officer appointment.
Quick Heal Technologies Ltd reported revenue from operations of ₹64.9 Cr (-22.3% YoY) and net profit of ₹5.8 Cr (-26.6% YoY) for Q2 FY27.
Quick Heal Technologies Ltd will hold a board meeting on October 27, 2026, to approve unaudited financial results for the quarter ended September 30, 2026.
Quick Heal Technologies Ltd has filed its quarterly Shareholding Pattern for the period ended September 30, 2026, as per SEBI regulations.
Mr. Sarang Deshpande has resigned as Company Secretary and Key Managerial Personnel of Quick Heal Technologies Limited, effective on or before October 27, 2026.
Quick Heal Technologies responded to NSE's volume surveillance query, stating the trading increase is driven by market forces. No undisclosed material information exists.
Quick Heal Technologies Limited has allotted 2,431 equity shares following the exercise of options under its ESOP Scheme 2021. The post-allotment paid-up capital stands at Rs. 54.27 Crore.
Quick Heal Technologies Limited shareholders approved the re-appointment of Mr. Richard Stiennon as a Non-Executive Independent Director for a second five-year term, effective September 27, 2026.
Quick Heal Technologies held its 31st Annual General Meeting on September 23, 2026, to conduct business, including the adoption of financial statements and director appointments.
Quick Heal Technologies' Chief Marketing Officer, Sudhanshu Tripathi, has resigned from the company effective September 16, 2026, to pursue other professional opportunities.
Quick Heal Technologies responded to NSE's volume-spurt query, stating all Reg 30 disclosures were made. The company attributes the increase to normal market forces with no undisclosed material event.
Quick Heal Technologies Limited has allotted 9,746 equity shares following the exercise of options under its ESOP Scheme 2021. The exercise prices ranged from ₹114 to ₹122.
Quick Heal Technologies Ltd has appointed Mr. Amit Chaudhary as Vice President – Product Management. This appointment is effective from September 01, 2026.
Quick Heal Technologies Limited has shared the link to its Integrated Annual Report for FY 2025-26 and reminded shareholders to update their KYC details.
Quick Heal Technologies filed its Integrated Annual Report for FY 2025-26. The company also announced its 31st AGM scheduled for September 23, 2026.
Quick Heal Technologies Limited has scheduled its 31st Annual General Meeting for September 23, 2026. The meeting will be conducted via video conferencing with remote e-voting available.